Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Malone

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
ISRN Radiology|June 27, 2014
Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry MethodsLindsay A Beaton, Leonora Marro, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcomeShawn Malone, Gad Perry, Libni Eapen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
Helical Tomotherapy Versus 3-Dimensional Conformal Radiation Therapy in High-Risk Prostate Cancer: A Phase 3 Randomized Controlled TrialSoumyajit Roy, Robert MacRae, Scott Grimes, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
Patient-Reported Outcomes From a Phase 3 Randomized Controlled Trial Exploring Optimal Sequencing of Short-Term Androgen Deprivation Therapy With Prostate Radiation Therapy in Localized Prostate CancerSoumyajit Roy, Scott Grimes, Scott Carlyle Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2020
Impact of Sequencing of Androgen Suppression and Radiation Therapy on Testosterone Recovery in Localized Prostate CancerSoumyajit Roy, Scott Grimes, Libni Eapen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2012
Chromosome damage and cell proliferation rates in in vitro irradiated whole blood as markers of late radiation toxicity after radiation therapy to the prostateLindsay A Beaton, Catherine Ferrarotto, Leonora Marro, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
Journal of Applied Clinical Medical Physics|February 9, 2018
Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysisSaif Aljabab, Balamurugan Vellayappan, Eric Vandervoort, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2012
Postoperative radiotherapy in prostate cancer: the case of the missing targetJennifer Croke, Shawn Malone, Nicolas Roustan Delatour, et al.
Cancer|June 20, 2006
Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parametersNicholas Bruchovsky, Laurence Klotz, Juanita Crook, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
ISRN Radiology|June 27, 2014
Investigating γ H2AX as a Biomarker of Radiosensitivity Using Flow Cytometry MethodsLindsay A Beaton, Leonora Marro, Shawn Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcomeShawn Malone, Gad Perry, Libni Eapen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2024
Helical Tomotherapy Versus 3-Dimensional Conformal Radiation Therapy in High-Risk Prostate Cancer: A Phase 3 Randomized Controlled TrialSoumyajit Roy, Robert MacRae, Scott Grimes, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2021
Patient-Reported Outcomes From a Phase 3 Randomized Controlled Trial Exploring Optimal Sequencing of Short-Term Androgen Deprivation Therapy With Prostate Radiation Therapy in Localized Prostate CancerSoumyajit Roy, Scott Grimes, Scott Carlyle Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2020
Impact of Sequencing of Androgen Suppression and Radiation Therapy on Testosterone Recovery in Localized Prostate CancerSoumyajit Roy, Scott Grimes, Libni Eapen, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2012
Chromosome damage and cell proliferation rates in in vitro irradiated whole blood as markers of late radiation toxicity after radiation therapy to the prostateLindsay A Beaton, Catherine Ferrarotto, Leonora Marro, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancerJuanita Crook, Charles Ludgate, Shawn Malone, et al.
Journal of Applied Clinical Medical Physics|February 9, 2018
Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysisSaif Aljabab, Balamurugan Vellayappan, Eric Vandervoort, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2012
Postoperative radiotherapy in prostate cancer: the case of the missing targetJennifer Croke, Shawn Malone, Nicolas Roustan Delatour, et al.
Cancer|June 20, 2006
Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parametersNicholas Bruchovsky, Laurence Klotz, Juanita Crook, et al.
Pageof 12